Tag Archives: biotechnology

Genetic Technologies Affirms Ariosa/Myriad With An Introduction By The Sequenom Petition for Cert.

Posted on April 11, 2016 by Warren Woessner

On April 1st, Lilly filed an amicus brief in favor of Sequenom’s petition for cert. seeking to reverse Ariosa, that caused a lot of buzz in the IP community. (A copy is available at the end of this post.) To … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged biotechnology, biotechnology law, Eli Lilly, Federal Circuit, Mayo, Myriad, Patent Law, Supreme Court, Warren Woessner | 1 Comment

Superman Breyer v. Batman Lourie Battle in the Sequenom Petition for Cert.

Posted on March 27, 2016 by Warren Woessner

Since this is an amplification of my last post on the Sequenom petition for cert. in Sequenom v. Ariosa, please go back at read my first post on the petition. I have been arguing for some years that the patent … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Ariosa v. Sequenom, biotechnology, biotechnology law, Federal Circuit, intellectual property, ip, Patent Law, patents, Supreme Court, USPTO, Warren Woessner | Leave a comment

Sequenom Files Petition for Cert. After Invalidation of Cff Patent

Posted on March 22, 2016 by Warren Woessner

Sequenom, the loser in “Ariosa,” has filed a petition seeking Supreme Court review of the Fed. Cir.’s invalidation of the claims of US Pat. No. 6,258,540 as an attempt to claim a natural product, cffDNA. While there is no dispute … Continue reading →

Labeling GMO’s — Too Late and Too Much

Posted on January 29, 2016 by Warren Woessner

Commentators arguing that genetically-modified plants (and animals) or “GMO’s” have been prepared by conventional plant breeding, fail to address the central issue driving the debate about the safety of genetically-engineered crops intended for human consumption. The issue is not whether … Continue reading →